NOT-HL-19-718: Notice of Expiration of RFA-HL-19-014 Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE) (R01 Clinical Trial Not Allowed)

Notice of Expiration of RFA-HL-19-014 Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE) (R01 Clinical Trial Not Allowed)

Notice Number: NOT-HL-19-718

Key Dates
Release Date: August 27, 2019

Related Announcements
RFA-HL-19-014
NOT-HL-19-715

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to announce the expiration of RFA-HL-19-014, "Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE) (R01 Clinical Trial Not Allowed),” effective upon publication of this Notice. This will negate the FOA’s final application due date of June 15, 2020.

In lieu of RFA-HL-19-014, potential applicants are directed to NOT-HL-19-715, “Notice of Intent to Publish: Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE-2) (R61/R33 Clinical Trial Required).

Inquiries

Please direct all inquiries to:

Rebecca A. Roper, MS, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-496-1051
Email: rebecca.roper@mail.nih.gov